VIR — VIR BIOTECHNOLOGY INC COM

Ownership history in Parallel Advisors, LLC  ·  20 quarters on record

This page tracks every 13F SEC filing in which Parallel Advisors, LLC reported a position in VIR BIOTECHNOLOGY INC COM (VIR). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.

Peak position
0.06% (2021 Q2)
Avg. % of fund
0.01%
First filed
2020 Q2
Last filed
2025 Q3
Quarters held
20
Quarter Action Shares Change Chg % % of Fund Mkt Value Price (EOQ)
2025 Q3 UNCHANGED 468 — 0% 0.00% $3K $5.71
2025 Q2 REDUCED 468 -44 -8.6% 0.00% $2K $5.04
2025 Q1 UNCHANGED 512 — 0% 0.00% $3K $6.48
2024 Q4 UNCHANGED 512 — 0% 0.00% $4K $7.34
16 older quarters hidden  —  Sign in free or upgrade to Premium to see full history
% of Fund (quarterly)    VIR price (monthly, adj. close)

Other funds also holding VIR

As of 2025 Q4 — sorted by position size

ARCH Venture Management, LLC 3Y 7Y 11.95% GSK plc 6.45% GordonMD Global Investments LP 4.02% SB INVESTMENT ADVISERS (UK) LTD 3Y 7Y 0.79% Sio Capital Management, LLC 3Y 7Y 0.45% Tejara Capital Ltd 3Y 0.33% Eagle Health Investments LP 3Y 0.32% ORBIMED ADVISORS LLC 3Y 7Y 0.29% Ikarian Capital, LLC 3Y 0.27% Clarius Group, LLC 3Y 7Y 0.21%
← Back to Parallel Advisors, LLC Holdings